Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
Takeda has granted commercialization rights to Aska Pharmaceuticals in Japan for the investigative therapy relugolix for the treatment of uterine fibroids, and development and commercialization rights for the treatment of endometriosis. Takeda has the ... Read more
The properties of AbbVie‘s elagolix (ABT-620), an investigative therapy for treating endometriosis and uterine fibroids, were found to be similar in women with and without endometriosis, researchers found. These findings ... Read more
Fewer women are undergoing hysterectomies in the U.S, due to the rise of simpler, less-invasive procedures. That finding and more are detailed in the study “Nationwide Trends in the Utilization ... Read more
Doctors could do a better job of addressing the psychological and social concerns of women with endometriosis, a condition that can impact patients’ intimate relationships and self-perception, according to a ... Read more